Literature DB >> 36186218

Synchronous primary duodenal papillary adenocarcinoma and gallbladder carcinoma: A case report and review of literature.

Jing Chen1, Ming-Yuan Zhu2, Yan-Hua Huang1, Zhong-Cheng Zhou1, Yi-Yu Shen1, Quan Zhou3, Ming-Jian Fei3, Fan-Chuang Kong1.   

Abstract

BACKGROUND: Synchronous primary cancers (SPCs) have become increasingly frequent over the past decade. However, the coexistence of duodenal papillary and gallbladder cancers is rare, and such cases have not been previously reported in the English literature. Here, we describe an SPC case with duodenal papilla and gallbladder cancers and its diagnosis and successful management. CASE
SUMMARY: A 68-year-old Chinese man was admitted to our hospital with the chief complaint of dyspepsia for the past month. Contrast-enhanced computed tomography of the abdomen performed at the local hospital revealed dilatation of the bile and pancreatic ducts and a space-occupying lesion in the duodenal papilla. Endoscopy revealed a tumor protruding from the duodenal papilla. Pathological findings for the biopsied tissue revealed tubular villous growth with moderate heterogeneous hyperplasia. Surgical treatment was selected. Macroscopic examination of this surgical specimen revealed a 2-cm papillary tumor and another tumor protruding by 0.5 cm in the gallbladder neck duct. Intraoperative rapid pathology identified adenocarcinoma in the gallbladder neck duct and tubular villous adenoma with high-grade intraepithelial neoplasia and local canceration in the duodenal papilla. After an uneventful postoperative recovery, the patient was discharged without complications.
CONCLUSION: It is essential for clinicians and pathologists to maintain a high degree of suspicion while evaluating such synchronous cancers. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Case report; Duodenal papillary adenocarcinoma; Gallbladder carcinoma; Surgical treatment; Synchronous primary cancers

Year:  2022        PMID: 36186218      PMCID: PMC9516900          DOI: 10.12998/wjcc.v10.i27.9790

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.534


Core Tip: Synchronous primary cancers (SPCs) of the duodenal papilla and gallbladder are rarely reported. Here, we report such a case. The lesion in the duodenal papilla was discovered by imaging examination of a 68-year-old man. Endoscopic biopsy was performed, and the pathological findings revealed moderate heterogeneous hyperplasia. The patient underwent pancreaticoduodenectomy, and intraoperative rapid histopathological examination surprisingly revealed adenocarcinoma in the papillary region and another adenocarcinoma in the gallbladder neck duct. SPC involving both the gallbladder and duodenal papilla is regarded as a rare occurrence. It is essential for the clinician and pathologist to maintain a high degree of suspicion while evaluating such lesions.

INTRODUCTION

With the widespread improvement in early diagnosis and regular medical check-ups, the occurrence of synchronous primary cancers (SPCs) has become increasingly frequent over the past decade[1]. However, it is very rare for duodenal papillary and gallbladder cancers to coexist, and no cases have been reported in the English literature. Here, we describe a case of SPC of the duodenal papilla and gallbladder and its diagnosis and successful management.

CASE PRESENTATION

Chief complaints

A 68-year-old Chinese man was admitted to a local hospital with the chief complaint of dyspepsia.

History of present illness

The patient’s symptoms started a month prior to dyspepsia.

History of past illness

The patient had a history of distal gastric resection with Billroth II anastomosis for a bleeding marginal ulcer 30 years ago.

Personal and family history

The patient denied any family history.

Physical examination

After hospitalization, the patient’s temperature was 37°C, heart rate was 88 beats per minute, respiratory rate was 19 breaths per minute, blood pressure was 127/79 mmHg and oxygen saturation in room air was 100%. The clinical examination showed no pathological signs.

Laboratory examinations

Blood tests, including tumor markers, showed that levels were completely normal except for glutamyl transpeptidase (GGT; 379 U/L, normal: 10-60 U/L) and alkaline phosphatase (ALP; 174 U/L, normal: 45-125 U/L).

Imaging examinations

Contrast-enhanced computed tomography of the upper abdomen performed at the local hospital revealed dilatation of the intrahepatic bile duct, common bile duct and pancreatic duct and a space-occupying lesion in the duodenal papilla (Figure 1).
Figure 1

Contrast-enhanced computed tomography of the abdomen. A: Space-occupying lesion in the duodenal papilla (orange arrowheads) and dilatation of the common bile duct (blue arrowheads); B: dilatation of extrahepatic bile duct (orange arrowheads).

Contrast-enhanced computed tomography of the abdomen. A: Space-occupying lesion in the duodenal papilla (orange arrowheads) and dilatation of the common bile duct (blue arrowheads); B: dilatation of extrahepatic bile duct (orange arrowheads). Endoscopic biopsy was performed because of the unclear nature of this occupancy. Endoscopy showed a tumor protruding from the duodenal papilla (Figure 2), and the pathological findings revealed that the biopsy tissue presented tubular villous growth with moderate heterogeneous hyperplasia (Figure 3).
Figure 2

Endoscopic biopsy. Tumor protruding from the duodenal papilla.

Figure 3

Histopathological findings of endoscopic biopsy. A: Tubular villous growth. B: Moderate heterogeneous hyperplasia.

Endoscopic biopsy. Tumor protruding from the duodenal papilla. Histopathological findings of endoscopic biopsy. A: Tubular villous growth. B: Moderate heterogeneous hyperplasia.

FINAL DIAGNOSIS

Based on the above physical examination features and imaging data, a provisional diagnosis of space-occupying lesion in the duodenal papilla was made. After surgical resection, the final diagnoses were gall bladder adenocarcinoma and duodenal papilla adenocarcinoma.

TREATMENT

Since malignancy of the space-occupying lesion in the duodenal papilla could not be ruled out, surgical treatment was selected after communication with the patient and his family members. The patient was informed of the possible risks involved in this surgery before consent for the operation was obtained. Based on a careful preoperative evaluation and no obvious findings of contraindications of the surgery, the patient underwent a pancreaticoduodenectomy (Whipple’s procedure) on July 11, 2019. Macroscopic examination of this surgical specimen revealed a 2-cm papillary tumor and another tumor with a 0.5-cm protrusion in the gallbladder neck duct (Figure 4). Intraoperative rapid pathology revealed adenocarcinoma without basement membrane breakthrough in the gallbladder neck duct and tubular villous adenoma with high-grade intraepithelial neoplasia and local canceration in the duodenal papilla. The examination also showed that no metastases were found in the resected lymph nodes. The cooccurrence of duodenal papillary and gallbladder cancers is very rare. The two tumors were independent of each other, and there was no relationship with metastasis.
Figure 4

Macroscopic appearance of the surgical specimen. Papillary tumor (red circle) and gallbladder neck duct tumor (yellow circle) were present in the specimen.

Macroscopic appearance of the surgical specimen. Papillary tumor (red circle) and gallbladder neck duct tumor (yellow circle) were present in the specimen.

OUTCOME AND FOLLOW-UP

The final pathological tumor stage was pT1bN0M0 for adenocarcinoma of the gall bladder and pT1N0M0 for adenocarcinoma of the duodenal papilla, and the patient was not provided adjuvant therapy. After an uneventful recovery, the patient was discharged without complications on postoperative Day 20. After one year, he was followed up by us, and there was no evidence of tumor recurrence.

DISCUSSION

The most common synchronous cancers are colorectum (37.2%), lung (18.6%), esophagus (16.8%), liver (9.7%), kidney (4.4%) and stomach (3.4%)[2]. The simultaneous occurrence of multiple cancers in the papilla of Vater and ampulla of Vater is rare, with approximately 7 cases and 14 cases, respectively, reported thus far in the English-language medical literature[3-21] (Table 1). However, this report is the first to detail the SPC of the duodenal papilla and gallbladder. The incidence of SPC from the biliary tree has been reported to vary from 5.0 to 7.4%[22], and it is important to distinguish between SPC and secondary deposits. The following diagnostic criteria have been adopted by most clinicians to differentiate synchronous primaries from malignant deposits: (1) Lack of anatomical continuity between two tumors; (2) a growth pattern typical of a primary tumor; and (3) clear histological differences between two tumors[23,24]. According to the above criteria, this case was determined to be SPC. Ultimately, both the gallbladder and duodenal papilla were labeled as primary adenocarcinomas by the pathologist as they had histological differences and a growth pattern typical of a primary tumor.
Table 1

Literature review of synchronous primary cancers occurring in the papilla/ampulla of Vater and other organs

Cases Age (yr)/Sex Tumor location Treatment Prognosis (mo)
Ueno et al[3] 58/MCommon bile duct, gallbladder, papilla of Vater (severe dysplasia)Surgical resection30/Disease-free survival
Seo et al[4] 42/FMajor and minor duodenal papilla of VaterEndoscopic papillectomy16/Disease-free survival
Parthasarathy et al[5] 60/FMajor and minor duodenal papilla of VaterSurgical resection8/Disease-free survival
Matheus et al[6] 50/FMajor and minor duodenal papilla of VaterSurgical resection24/Disease-free survival
Tamura et al[7]78/MLung, papilla of VaterSurgical resection60/Disease-free survival
Takahashi et al[8]66/MErythroleukemia,stomach, papilla of VaterJejuno-choledochostomyN/A
Nishihara et al[9]53/Mcommon bile duct, pancreas,papilla of VaterSurgical resectionN/A
de Garcia de la Vega et al[10] 77/MEsophagus, ampulla of VaterSurgical resection24/Recurrence due to liver metastasis
Sastry et al[11]81/MPancreas, ampulla of VaterSurgical resection10/Die of liver metastasis
Cokmert et al[12]63/Fsigmoid colon, ampulla of VaterSurgical resectionN/A
Fukaya et al[13]69/Mesophagus, stomach, ampulla of VaterSurgical resection12/Die of progressive disease
Wohlauer et al[14] 76/Mcommon bile duct, ampulla of VaterSurgical resectionN/A
Rajalingam et al[15]72/Mright colon, ampulla of VaterSurgical resection8/Disease-free survival
Aurello et al[16]33/FDuodenum, ampulla of VaterSurgical resection24/Disease-free survival
Athanasopoulos et al[17]43/Mcommon bile duct, ampulla of VaterSurgical resection18/Disease-free survival
Eriguchi et al[18]83/MStomach, ampulla of VaterSurgical resection3/Disease-free survival
Eriguchi et al[18]74/MColon, ampulla of VaterSurgical resection24/ Die of liver metastasis
Eriguchi et al[18]68/MRenal pelvis, ampulla of VaterSurgical resection14/ Die of progressive disease
Mafune et al[19]64/MEsophagus, ampulla of VaterSurgical resection13/Disease-free survival
González Sánchez et al[20]50/FColon, ampulla of VaterSurgical resectionN/A
Yoshida et al[21]58/MSigmoid colon, ampulla of VaterSurgical resectionN/A

N/A: Not applicable.

Literature review of synchronous primary cancers occurring in the papilla/ampulla of Vater and other organs N/A: Not applicable. To date, the pathogenesis of SPC has not been elucidated. Several factors are involved, including genetic factors, environmental carcinogens, hormones, dietary factors, previous therapy, infective agents, smoking and alcohol use[25,26]. First, gallbladder cancer may be caused by infectious agents or gallstones due to chronic inflammation and recurrent trauma[27,28]. A reasonable assumption indicates that chronic irritation of the mucosa leads to dysplasia and causes malignant changes[29]. Additionally, 62.5% of SPCs of the biliary tract have been reported to be associated with abnormal pancreaticobiliary junction (APBJ) caused by persistent reflux of pancreatic juice with subsequent biliary inflammation[30-32]. In our case, the cystic duct was too long and had low confluence with the common bile duct. An excessively long cystic duct is adverse to bile outflow, and the duct can be easily blocked and infected by gram-negative bacilli. Eventually, these factors may lead to tumorigenesis. Second, duodenal papillary adenocarcinoma is a relatively uncommon malignant tumor that accounts for less than 1% of all gastrointestinal cancers[33]. Smoking is an important risk factor, and chronic infection and heredity are considered important susceptibility factors[18]. In the process of canceration, mutations in genes such as K-ras, p53 and p21/Waf1 play an important role[34,35]. Preoperative diagnosis of duodenal papilla occupancy is useful for making therapeutic decisions. Endoscopic biopsy has become a popular diagnostic tool and is used in a diverse range of digestive tract diseases. Histopathology from biopsy remains the gold standard for diagnosis. The positive rate of endoscopic biopsy is low, although the diagnostic value of the endoscopic appearance seems to be superior to that of endoscopic biopsy[36]. In the study case, endoscopy revealed a tumor protruding from the duodenal papilla, and endoscopic biopsy did not diagnose a malignant tumor. These findings demonstrated the importance of the endoscopic description of duodenal papilla. In addition, we were unable to diagnose this gallbladder carcinoma preoperatively. The presence of SPC was a histological surprise. Few reports have focused on the treatment of patients with this rare disease, which remains a key challenge[37]. Curative resection, if possible, is the most effective method of prolonging patient survival. It is also important to note that surgical procedures may not necessarily lead to better prognosis in patients with SPC. Hepatopancreatoduodenectomy is indicated in locally advanced GBC patients with extensive retropancreatic lymphadenopathy that cannot be cleared without pancreatoduodenectomy. Moreover, HPD is associated with significant morbidity, with an overall major complication rate of approximately 50%. Thus, avoiding extensive hepatectomy has reduced morbidity after HPD[38,39]. In this case, a malignant tumor of the duodenal papilla could not be excluded, and the patient successfully underwent pancreaticoduodenectomy. To our surprise, adenocarcinoma of the gallbladder neck duct and involvement in the muscularis were discovered. Because the cystic duct presents low confluency with the common bile duct and the tumor was located on the gallbladder neck duct, no further treatment was needed, and an R0 resection was achieved with the classical Whipple’s procedure. After an uneventful postoperative recovery, the patient was discharged without complications. The follow-up data 1 year after the operation were collected, and no tumor recurrence or metastasis was found.

CONCLUSION

SPC involving both the gallbladder and duodenal papilla is regarded as a rare occurrence but is becoming increasingly common during hepatobiliary surgery. It is essential for clinicians and pathologists to maintain a high degree of suspicion while evaluating these lesions and to look for the existence of APBJ. At the same time, it is necessary to develop a more accurate diagnostic tool and implement more refined treatment strategies to correctly diagnose SPC.
  39 in total

1.  Synchronous adenocarcinoma of the gall bladder and pancreas in a young woman.

Authors:  Nitin Agarwal; Sunil Kumar; Sonal Sharma
Journal:  Trop Gastroenterol       Date:  2013 Jan-Mar

2.  Double Trouble: Synchronous Adenocarcinoma of Gallbladder and Pancreas.

Authors:  Pavankumar Vijayaraj; Sandip Chandrasekar; Raja Kalayarasan; Biju Pottakkat
Journal:  J Gastrointest Cancer       Date:  2018-09

Review 3.  Carcinoma in adenoma of the ampulla of Vater synchronous with cancer of the sigmoid colon.

Authors:  J Yoshida; T Morisaki; K Yamaguchi; T Itoh; K Yokohata; H Kishikawa; H Iino
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

4.  [Carcinoma of the Vater's ampulla and colonic carcinoma with synchronous onset].

Authors:  J A González Sánchez; F López-Ríos Fernández; R González Conde; J E Miguel Velasco; M S Casas Pinillos; J Larrauri Martínez
Journal:  Rev Esp Enferm Dig       Date:  1993-06       Impact factor: 2.086

5.  Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?

Authors:  Yoshihiro Sakamoto; Satoshi Nara; Yoji Kishi; Minoru Esaki; Kazuaki Shimada; Norihiro Kokudo; Tomoo Kosuge
Journal:  Surgery       Date:  2013-02-13       Impact factor: 3.982

6.  Carcinoma of the papilla of Vater: are endoscopic appearance and endoscopic biopsy discordant?

Authors:  Michelle Lucinda DeOliveira; Tarcisio Triviño; Gaspar de Jesus Lopes Filho
Journal:  J Gastrointest Surg       Date:  2006 Sep-Oct       Impact factor: 3.452

7.  Studies on biliary tract carcinoma in the case with pancreaticobiliary maljunction.

Authors:  Hitoshi Hara; Shinsho Morita; Takashi Ishibashi; Shozo Sako; Takehiko Dohi; Masahiro Otani; Mitsuhiko Iwamoto; Hitoshi Inoue; Nobuhiko Tanigawa
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

8.  Three synchronous carcinomas of the papilla of Vater, common bile duct and pancreas.

Authors:  K Nishihara; M Tsuneyoshi; H Shimura; Y Yasunami
Journal:  Pathol Int       Date:  1994-04       Impact factor: 2.534

Review 9.  Pathogenesis of carcinoma of the papilla of Vater.

Authors:  Hans-Peter Fischer; Hui Zhou
Journal:  J Hepatobiliary Pancreat Surg       Date:  2004

10.  Synchronous abdominal tumors: is combined laparoscopic surgery in a single approach a safe option?

Authors:  Marcelo Cartapatti; Roberto Dias Machado; Roberto Lodeiro Muller; Wesley J Magnabosco; Alexandre César Santos; Brian Francis Chapin; Armando Melani; Antonio Talvane; Marcos Tobias-Machado; Eliney Ferreira Faria
Journal:  Int Braz J Urol       Date:  2018 May-Jun       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.